RxDoctor Payments Data

Alan Schneider, MD

Clinical Cardiac Electrophysiology · Silver Spring, MDNPI 1073692885

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,121 of the $1,463 with a category attached, or 76.6%. Abbott accounts for 97.4% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $1,247 and has fallen 97.0% since, to $38 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MD, where the typical reported total is $15,262.

$1,463in general payments, 2019–2025

Across 19 payments — averaging $76.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Philips North America LLC$38

What the payments were for

  • Travel & lodging$1,12177%
  • Food & beverage$34223%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott18$1,425
Philips North America LLC1$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,463 in reported general payments places this provider in the 10th percentile of 63 clinical cardiac electrophysiology providers in Maryland.

See all clinical cardiac electrophysiology providers in Maryland

Medicare billing

Part B allowed, 2024
$517,180
Medicare patients
1,567
Services billed
6,577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban493$681,627
XareltoRivaroxaban107$163,141
EntrestoSacubitril/Valsartan72$113,828
Repatha SureclickEvolocumab14$22,024
Metoprolol Succinate356$8,314
SavaysaEdoxaban Tosylate11$5,294
Atorvastatin Calcium300$4,684
Amiodarone Hcl112$4,322
Dabigatran EtexilateDabigatran Etexilate Mesylate14$2,784
Amlodipine Besylate305$2,762
Propafenone Hcl ErPropafenone Hcl12$2,278
Droxidopa16$2,248
Rosuvastatin Calcium89$2,116
Valsartan27$1,665
Flecainide Acetate39$1,627

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Silver Spring

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →